Peripheral Artery Disease (PAD)

This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia.

The U.S. Food and Drug Administration (FDA) has issued a Letter to Health Care Providers about updated information associated with paclitaxel-coated devices used to treat peripheral arterial disease (PAD)

News | Peripheral Artery Disease (PAD)

Paclitaxel-Coated Devices to Treat Peripheral Arterial Disease Unlikely to Increase Risk of Mortality

July 11, 2023 — The U.S. Food and Drug Administration (FDA) is informing healthcare providers about updated information ...

July 11, 2023

Qardio, a leading innovator in healthcare technology, has unveiled its groundbreaking Livestream solution suite, which includes continuous ECG, Blood Pressure, Pulse Oximetry (SPO2), Body Temperature, Weight, and Body Position monitoring

News | Cath Lab

Philips and BIOTRONIK Expand Care for Out-of-hospital Cardiology Labs with New Strategic Alliance

June 21, 2023 — Royal Philips, a global leader in health technology, announced it has teamed up with BIOTRONIK (Lake ...

June 21, 2023

News | Peripheral Artery Disease (PAD)

American Heart Association Releases Scientific Statement on Reducing Disparities in Peripheral Artery Disease with Routine Tests

June 21, 2023 — A new science report issued by the American Heart Association (AHA) emphasizes the importance of ...

June 21, 2023

Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted approval for the DETOUR System to treat patients with complex peripheral arterial disease (PAD).

News | Peripheral Artery Disease (PAD)

Endologix Announces 24-Month Results of DETOUR- 2 Study at 2023 Vascular Annual Meeting

June 16, 2023 — Endologix LLC, a privately held, global medical device company, dedicated to providing disruptive ...

June 16, 2023

News | Peripheral Artery Disease (PAD)

Endologix Receives FDA Approval of the DETOUR System to Treat Long Complex Superficial Femoropopliteal Lesions in Patients with PAD

June 15, 2023 — Endologix LLC, a privately held, global medical device company dedicated to providing disruptive ...

June 15, 2023

MagicTouch PTA -Sirolimus Coated Balloon has recently received IDE approval from the US FDA for SFA indication

News | Drug-Eluting Balloons

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

May 30, 2023 — The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Conce ...

May 30, 2023

Findings from a study examining the relationship between marijuana use and peripheral artery disease (PAD) were presented during the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions, held May 18-20 in Phoenix, AZ. Results found marijuana users are at a significantly increased risk of developing PAD, compared to the general population.

News | SCAI

Marijuana Users Three Times More Likely to Develop Peripheral Artery Disease

May 19, 2023 — Findings from a study examining the relationship between marijuana use and peripheral artery disease (PAD ...

May 19, 2023

Along with this latest IDE approval for the treatment of Small Vessel indication, Concept Medical received two other IDE approvals for the Magic Touch SCB family of products for the treatment of coronary In-Stent Restenosis (ISR) indication and Below-the-Knee indication (PTA)

News | Drug-Eluting Balloons

Concept Medical's Receives FDA Approval for the MagicTouch-Sirolimus Coated Balloon

May 12, 2023 — The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s novel ...

May 12, 2023

FastWave Medical, a privately-held company founded by Big Sky Biomedical partners, announces the issuance of its second utility patent by the USPTO. This milestone showcases FastWave Medical's unparalleled efficiency in developing novel intravascular lithotripsy (IVL) systems to address the $9 billion market.

News | Embolic Protection Devices

FastWave Medical Granted Second Utility Patent to Advance the Future of Cardiovascular Calcium Treatment

April 25, 2023 — FastWave Medical, a privately-held company founded by Big Sky Biomedical partners, announces the ...

April 25, 2023

Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in women, according to a review published today in European Heart Journal – Quality of Care and Clinical Outcomes, a journal of the European Society of Cardiology (ESC)

News | Peripheral Artery Disease (PAD)

Clogged Leg Arteries Underdiagnosed and Undertreated in Women

March 8, 2023 — Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in ...

March 08, 2023

Salim Virani, MD, PhD, staff cardiologist at the Michael E. DeBakey VA Medical Center in Houston, vice provost for research and professor at the Aga Khan University in Karachi, Pakistan, and staff at The Texas Heart Institute/Baylor College of Medicine.

News | Peripheral Artery Disease (PAD)

Targeted Reminders Increase Prescriptions for High-Intensity Statins

March 5, 2023 — Patients with cardiovascular disease, such as heart disease, stroke or peripheral arterial disease, were ...

March 05, 2023

Northeast Scientific Inc., the pioneers in reprocessing single use peripheral vascular catheters, announced this week it has received FDA 510(k) clearance for reprocessing the Philips IVUS Eagle Eye Platinum RX Digital catheter.

News | Intra-Vascular Ultrasound (IVUS)

Northeast Scientific Inc. awarded 510(k) clearance to reprocess the Eagle Eye Platinum RX Digital IVUS Catheter

February 16, 2023 — Northeast Scientific Inc., the pioneers in reprocessing single use peripheral vascular catheters ...

February 16, 2023

$Neovasc’s Innovative Reducer System will target the estimated $5 billion refractory angina market$

News | Cardiovascular Business

Shockwave Medical Announces Agreement to Acquire Neovasc

January 19, 2023 — Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat ...

January 19, 2023

News | Embolic Protection Devices

Shockwave Intravascular Lithotripsy-assisted TMVR Shows Promise for Patients with Severe Stenosis and Regurgitation

January 11, 2023 — In recent years, transcatheter mitral valve replacement (TMVR) treatment and technology has evolved ...

January 11, 2023

News | Peripheral Artery Disease (PAD)

Modern Vascular and Local Interventional Radiologist Pair Up To Reduce Unnecessary Amputations in Houston, Texas

December 29, 2022 — Modern Vascular, the national leader in minimally invasive treatment for Peripheral Artery Disease ...

December 29, 2022